baber/WOPTO huggingface dataset:
Patent MX-2020005634-A (MX)
Title: Tumor-infiltrating lymphocytes for adoptive cell therapy.
Inventor: SARNAIK AMOD A
IPC: C12N5/0783
Filed: 2016-09-20
Abstract: Disclosed are compositions and methods for ex vivo expansion of tumorinfiltrating lymphocytes for use in adoptive cell therapy (ACT). Also disclosed are compositions and method for identifying an agent for ex vivo expansion of tumorinfiltrating lymphocytes for use in ACT. Also disclosed are methods for treating cancer using tumor-infiltrating lymphocytes expanded by the disclosed methods.
Patent MX-2020007045-A (MX)
Title: User terminal and wireless communication method.
Inventor: NAGATA SATOSHI
IPC: H04L27/26
Filed: 2018-01-05
Abstract: In order to appropriately perform communication even when controlling by switching between a plurality of bandwidth parts, one embodiment of the user terminal of the present disclosure has: a receiving unit for monitoring and receiving downlink control information which indicates slot format in a prescribed period; and a control unit for determining the slot format to be used during a prescribed interval in the frequency band after switching occurs on the basis of prescribed information transmitted by a base station, when controlling the transmission and/or receiving processing by switching between a plurality of frequency bands which are partially set in the frequency direction in a carrier.
Patent MX-2020012089-A (MX)
Title: Method for improving the productivity of grinding plants.
Inventor: PRIHODA HELMUT
IPC: B02C15/00
Filed: 2019-05-07
Abstract: The present invention relates to a method for improving the productivity of grinding plants, wherein, after the optimum wear geometry of the grinding units has been set, the optimum wear geometry is preserved by applying a thin wear protection layer to the surface of the grinding units by conventional operation of the grinding plant.
Patent MX-2020013016-A (MX)
Title: Seamless injection of augmented three-dimensional imagery using a positionally encoded video stream.
Inventor: PINTARIC MARIO
IPC: G06T7/50
Filed: 2019-05-30
Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for a multi-peer telepresence communications system. In one aspect, a method includes formulating a geometry of an environment based on sensor data collected from the environment by at least one sensor; capturing, with a camera, a plurality of video frames of the environment and associating each of the captured video frames with spatial transform data of the camera within the geometry of the environment; providing the video frames and associated camera position data to a remote peer; compositing, by the remote peer, the video frames and associated camera position data to generate a local composite; and displaying, on the remote peer, a three-dimensional augmented reality of the environment based on the local composite.
Patent MX-2021002500-A (MX)
Title: Novel antibodies and nucleotide sequences, and uses thereof.
Inventor: TEIGE INGRID
IPC: A61P35/00
Filed: 2019-09-03
Abstract: Described are novel anti-CTLA-4 antibody molecules and nucleotide sequences and expression vectors, such as viruses, encoding such antibody molecules. The novel antibody molecules are Treg depleting antibody molecules, and they have an improved depleting effect on CTLA-4 positive cells, such as Tregs, compared to ipilimumab. Described is also the use of such antibody molecules or nucleotide sequences or viruses in medicine, such as in the treatment of cancer, such as solid tumours.
Patent MX-2021004207-A (MX)
Title: Use of reboxetine to treat narcolepsy.
Inventor: TABUTEAU HERRIOT
IPC: A61K31/5375
Filed: 2019-10-14
Abstract: Described herein are methods of treating narcolepsy with cataplexy, comprising administering reboxetine to a human being in need thereof. Reboxetine may also be used in the manufacture of a medicament for the treatment of narcolepsy with cataplexy. Also disclosed herein are kits comprising a pharmaceutical composition comprising reboxetine and instructions to use the pharmaceutical composition to treat narcolepsy with cataplexy in a human being.
Patent MX-2021004386-A (MX)
Title: Novel compounds.
Inventor: ALVARO GIUSEPPE
IPC: C07D405/14
Filed: 2019-10-16
Abstract: A compound of formula (I): (Formula (I)) and related aspects.
Patent MX-2021004898-A (MX)
Title: Novel crispr/cas12f enzyme and system.
Inventor: LAI JINSHENG
IPC: C12N9/16
Filed: 2019-10-29
Abstract: The present invention belongs to the field of nucleic acid editing, in particular to the field of clustered regularly interspaced short palindromic repeats (CRISPR) technology. In particular, the present invention provides a Cas effector protein, a fusion protein comprising the Cas effector protein, and a nucleic acid molecule encoding the same. Also provided are a compound and a composition for nucleic acid editing (e.g., gene or genome editing) comprising the protein or the nucleic acid molecule, and a method for nucleic acid editing (e.g., gene or genome editing) using the protein.
Patent MX-2021005199-A (MX)
Title: Fluid exchange devices and related controls, systems, and methods.
Inventor: HAVRILLA NEIL
IPC: F04F13/00
Filed: 2019-11-08
Abstract: Pressure exchange devices, systems, and related methods may include a tank, a piston, a valve device, and one or more sensors for monitoring a position of the piston in the tank.
Patent MX-2021005855-A (MX)
Title: Image component prediction method, encoder, decoder, and storage medium.
Inventor: ZHANG WEI
IPC: H04N19/593
Filed: 2020-05-15
Abstract: Disclosed in embodiments of the present invention are an image component prediction method, an encoder, a decoder, and a storage medium. The method comprises: determining prediction parameters for a current block, wherein the prediction parameters include a prediction mode parameter and a size parameter of the current block; if the prediction mode parameter indicates that a matrix-based intra prediction (MIP) mode is to be used to determine an intra prediction value of the current block, determining an MIP weight matrix of the current block, a shift factor of the current block and an MIP input sample matrix of the current block; and determining an intra prediction value of the current block according to the MIP weight matrix, the shift factor and the MIP input sample matrix.
Patent MX-2021006206-A (MX)
Title: Non-aluminium antiperspirant compositions.
Inventor: ZDRAVKOVA ANELIYA NIKOLOVA
IPC: A61K8/58
Filed: 2019-10-23
Abstract: A non-aluminium antiperspirant aerosol composition comprising ethanol, amphiphilic material, volatile silicone and a hydrocarbon propellant, the amphiphilic material being a substance or mixture of substances which forms, upon contact with perspiration, a water- insoluble liquid crystal phase of greater than one dimensional periodicity.
Patent MX-2021007535-A (MX)
Title: Sequestering biomass in water.
Inventor: SLOCUM ALEXANDER
IPC: B63B35/32
Filed: 2019-12-23
Abstract: Buoyant matter, and particularly biomass such as seaweed, is sequestered deep in a body of water, fey causing the matter to lose it buoyancy and sink and remain sunk for an extended period. In some examples, the matter is pumped to below a depth at which is loses its natural buoyancy as a result of the ambient water pressure resulting in. it naturally sinking to the bottom.
Patent MX-2021008986-A (MX)
Title: Methods of treating a patient having parkinson's disease.
Inventor: BILBAUT THIERRY
IPC: A61K9/20
Filed: 2020-01-28
Abstract: Methods of treating a patient having Parkinson's disease, including treating "OFF" episodes and improving motor function, by administering apomorphine or a pharmaceutically acceptable salt thereof are disclosed herein. Supratherapeutic doses of apomorphine may be used. Apomorphine therapy may be used in place of levodopa therapy, or apomorphine may be used to supplant or augment the first levodopa dose of the day. Apomorphine therapy may involve administration of two consecutive apomorphine doses at least 2 hours apart.
Patent MX-2021011293-A (MX)
Title: Pulse delivery cleaning systems and methods.
Inventor: JOHNSON STEVEN A
IPC: B01D46/02
Filed: 2020-03-19
Abstract: A filter system includes a tube sheet defining a plurality of holes in fluid communication with a plurality of filter bags. The system also includes a rotating assembly having an arm defining one or more outlets to provide pressurized air from an air source toward the tube sheet in response to pulsing one or more actuators. A motor is operably coupled to the stationary assembly and the rotating assembly to rotate the arm about an axis at a preset rotational speed. A controller is operably coupled to the motor and the one or more actuators to provide pulse commands based on a pulse interval and a jog interval. The pulse interval and the jog interval may be determined based on a measured rotational speed of the arm, which may be redetermined during operation.
Patent MX-2021012903-A (MX)
Title: Modulators of the integrated stress response pathway.
Inventor: PALMER CHRISTOPHER FRANCIS
IPC: A61K31/4192
Filed: 2020-04-22
Abstract: The present invention relates to compounds of formula (I) or pharmaceutically acceptable salts, solvates, hydrates, tautomers or stereoisomers thereof, wherein R<sup>1</sup>, R<sup>2</sup>, R<sup>2a</sup>, R<sup>3</sup>, R<sup>a2</sup>, R<sup>a4</sup>, R<sup>a5</sup>, R<sup>a6</sup>, R<sup>a7</sup>, X<sup>1</sup>, X<sup>1a</sup>, A<sup>1</sup> and A<sup>2</sup> have the meaning as indicated in the description and claims. The invention further relates to pharmaceutical compositions comprising said compounds, their use as medicament and in a method for treating and preventing of one or more diseases or disorders associated with integrated stress response.
Patent MX-2021013381-A (MX)
Title: Preservative removal from eye drops.
Inventor: WILLIAMS MICHAEL
IPC: B01D15/00
Filed: 2020-04-30
Abstract: A particulate plug for removing a preservative from a solution, suspension, or emulsion comprising a drug is presented. The plug comprises microparticles of oxidized polyolefin (OxPO). The microparticles are irregular-shaped rigid aggregates and are sized and packed to yield a hydraulic permeability greater than 0.01 Da. The OxPO have absorbed portions of a preservative to be removed and/or a drug for delivery in solution, as can the copolymer.
Patent MX-2021015876-A (MX)
Title: Maternal plasma transcriptome analysis by massively parallel rna sequencing.
Inventor: LO YUK MING DENNIS
IPC: C12Q1/68
Filed: 2015-08-20
Abstract: Methods are provided for diagnosing pregnancy-associated disorders, determining allelic ratios, determining maternal or fetal contributions to circulating transcripts, and/or identifying maternal or fetal markers using a sample from a pregnant female subject. Also provided is use of a gene for diagnosing a pregnancy-associated disorder in a pregnant female subject.
Patent MX-2022000714-A (MX)
Title: Mapping restriction for intra-block copy virtual buffer.
Inventor: XU JIZHENG
IPC: H04N19/176
Filed: 2020-07-24
Abstract: A method for video processing is described. The method includes determining, for a conversion between a current video block of a video picture of a video and a coded representation of the video, a number of reference samples in a reference region of the video picture used for predicting the current video block, based on a rule, wherein the rule specifies that the number of reference samples is limited to a certain range; and performing, based on the determining, the conversion.
Patent MX-2022003318-A (MX)
Title: Meta-diamide insecticides.
Inventor: LONG JEFFREY KEITH
IPC: C07D213/75
Filed: 2020-09-20
Abstract: Disclosed are compounds of Formula 1, including all geometric and stereoisomers, N-oxides, and salts thereof, wherein Q, Y, R1a, R1b, Z, W, R2, R3, R4, m, R5a and R5b are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound or a composition of the invention.
Patent MX-2022004736-A (MX)
Title: 3-(4-(11h-dibenzo[b,e][1,4]azepin-6-yl)piperazin-1-yl)- and 3-(4-(dibenzo[b,f][1,4]oxazepin/thiazepin/diazepin-11-yl)pipera zin-1-yl)-propano ic acid derivatives as h1 and 5-ht2a-receptor modulators for the treatment of sleep disorders.
Inventor: DUGGAN MARK E
IPC: A61P25/20
Filed: 2020-10-20
Abstract: The present disclosure relates to 3-(4-(llH-dibenzo[b,e][l,4]azepin-6- yl)piperazin-l-yl)-, 3-(4-(dibenzo[b,f][l,4]oxazepin-ll-yl)piperazin-l- yl)-, 3-(4-(dibenzo[b,f][l,4]thiazepin-ll-yl)piperazin-l-yl)- and 3- (4-(dibenzo[b,f][l,4]diazepin-ll-yl)piperazin-l-yl)-propanoic acid derivatives of the formulae (I), (II1) and (II): wherein X is CR7R8, O, S or NR7, and to their pharmaceutically acceptable salts, pharmaceutical compositions, methods for their preparation, as well as to the compounds for use in methods of medical treatment. The compounds disclosed herein are useful for modulating HI and 5- HT2Areceptors and are to be used in the treatment of sleep disorders such as sleep fragmentation, disturbed sleep/arousals, and arousal threshold. The present description discloses the synthesis and characterisation of exemplary compounds as well as pharmacological data thereof (e.g. pages 143 to 224; examples 1 to 33; compounds 1 to 39; tables A to R). An exemplary compound is e.g. 3-(4-(7-chloro-3-methyldibenzo[b,f] [l,4]oxazepin-ll-yl)piperazin-l-yl)-2, 2-dimethyl propanoic acid (example 1, compound 1):.
Patent MX-2022005934-A (MX)
Title: Thermal interface materials and methods for application.
Inventor: JEWRAM RADESH
IPC: C09K5/10
Filed: 2020-11-19
Abstract: A thermal interface material delivered as a single-component precursor mixture which reacts to form a soft, solid material. Thermally conductive particles are dispersed in the reactive polymer matrix resulting in a composite material with high thermal conductivity. A reaction inhibitor is provided so that the one-component system is stable in storage and handling at room temperature, and curable at an elevated temperature. The uncured precursor material is easily dispensed using conventional single-component automated pumping equipment, and subsequently cured in place.
Patent MX-2022007679-A (MX)
Title: Purified compositions of enteroviruses and methods of purification with glutathione affinity chromatography.
Inventor: CURTIS ERIK M
IPC: C12N7/02
Filed: 2020-12-17
Abstract: The present invention relates to purified compositions of enteroviruses, pharmaceutical compositions thereof and a glutathione affinity chromatography process for the purification of enteroviruses.
Patent MX-2022007891-A (MX)
Title: Neuromodulation apparatus.
Inventor: DOSKOCIL LUKAS
IPC: A61N1/36
Filed: 2020-12-11
Abstract: A neuromodulation apparatus and method of using the same. The neuromodulation apparatus includes a plurality of electrodes each of the plurality of electrodes having an electrically conductive element applicable to or under a skin of a patient, a pulse generator electrically connected to each of the plurality of electrodes for transmitting electrical pulses to the plurality of electrodes and a control unit coupled to the pulse generator and adapted to measure a resistance and/or a current-voltage characteristic between at least two electrodes of the plurality of electrodes. The control unit is adapted to control a shape of the electric pulses based on the measured resistance and/or current-voltage characteristic.
Patent MX-2022009418-A (MX)
Title: Anti-transferrin receptor (tfr) antibody and uses thereof.
Inventor: SUBRAMANIAN ROMESH R
IPC: A61K38/02
Filed: 2021-01-08
Abstract: Aspects of the disclosure relate to antibodies that bind to transferrin receptor (e.g., transferrin receptor 1) and complexes comprising the antibody covalently linked to a molecular payload. Methods of making and using the antibodies are also provided.
Patent MX-2022010081-A (MX)
Title: Photochromic curable composition and photochromic optical article.
Inventor: MORI KATSUHIRO
IPC: C09K9/02
Filed: 2021-02-26
Abstract: The present invention provides: a photochromic curable composition which contains (A) a (meth)acrylate composition that contains from 24 to 100% by mass of a polyfunctional (meth)acrylate which has three or more (meth)acryloyl groups in each molecule and (B) a photochromic compound that is obtained by bonding at least one specific naphthopyran to a long-chain group having a number average molecular weight of from 300 to 10,000; and a photochromic optical article which is obtained by polymerizing this photochromic curable composition.
Patent MX-2022011022-A (MX)
Title: Compositions and systems for disinfection.
Inventor: MARKESBERY W RUSSELL
IPC: A01N25/02
Filed: 2021-03-05
Abstract: A disinfectant system, comprising a first aqueous composition having a peracid reactant compound that is either a peroxide compound or an organic acid compound, and a second aqueous composition comprising the peracid reactant compound not selected for the first composition. Each composition is applied separately to, and combined upon, a surface to form a reaction layer, within which a peracid is formed in situ, disinfecting the surface. The compositions can have a flash point, surface tension, and vapor pressure compatible for application as a spray, mist, aerosol, or fog, and can be formulated with an alcohol blend that enables the reaction layer to completely evaporate from the surface after disinfection is complete. In use, the disinfectant systems disclosed herein have up to 99.999% antimicrobial efficacy against organism such as Staphylococcus aureus, Pseudomonas aeruginosa, and Candida auris.
Patent MX-2022011351-A (MX)
Title: Steel sheet.
Inventor: SHUTO HIROSHI
IPC: C22C38/00
Filed: 2021-03-09
Abstract: This steel sheet has a predetermined chemical composition, Ex. C determined by the formula Ex. C = (%C) - 12[(%Ti*)/48 + (%V)/51 + (%Nb)/93 + (%Mo)/96 + (%W)/184] is 0.020% or less, the metallographic structure in a position at a depth of 1/4 of the sheet thickness from the surface thereof includes, in terms of area fraction, 60% or more of ferrite, 0-5% MA, and a total of 0-5% of pearlite and cementite, the remainder comprising bainite, and, in the metallographic structure, the average crystal grain size is 10.0 Âµm or less, the average aspect ratio of crystal grains is 0.30 or greater, the standard deviation of the Mn concentration is 0.60% by mass or less, Ti-based carbides having the Baker-Nutting orientation relationship in the ferrite are deposited in a semi-matched state, and the tensile strength of the steel sheet is 980 MPa or greater.
Patent MX-2022013182-A (MX)
Title: Treatment of cancers with an antibody that binds lgr5 and egfr.
Inventor: WASSERMAN ERNESTO ISAAC
IPC: C07K16/28
Filed: 2021-04-23
Abstract: The disclosure relates to means and methods in the treatment of cancer. The disclosure in particular relates to a method of treating a cancer in an individual with an antibody that binds LGR5 and EGFR. The invention further relates to the combination for use in such methods and to the combination for use in the manufacture of a medicament for the treatment of gastrointestinal cancer. Such antibodies are particularly useful in the treatment of gastric, esophageal, or gastro-esophageal-junction cancer.
Patent MX-2022016496-A (MX)
Title: A COMBINATION OF A CBP/p300 BROMODOMAIN INHIBITOR AND AN EGFR INHIBITOR FOR USE IN TREATING EGFR-MUTANT NSCLC.
Inventor: BOHNACKER THOMAS
IPC: A61K31/437
Filed: 2021-06-24
Abstract: The present invention is<i> inter alia</i> concerned with a combination of a CBP/p300 bromodomain inhibitor and an EGFR inhibitor for use in the treatment of a patient suffering from NSCLC, wherein the NSCLC exhibits an oncogenic alteration in the EGFR.
Patent MX-PA00000580-A (MX)
Title: Induction of male sterility in plants by expression of high levels of avidin.
Inventor: ALBERTSEN MARC C
IPC: A01H5/00
Filed: 1998-04-22
Abstract: Male-sterile plants can be produced by increasing the endogenous concentration of avidin in the plant tissues. This effect can be achieved by producing transgenic plants containing an expression vector in which a promoter is operably linked to a DNA sequence encoding avidin. Methods for restoring male fertility are disclosed. Additionally, methods for production of seeds with one or more desired grain traits are provided.
Patent MX-PA00012329-A (MX)
Title: Use of carbamate by-products in the treatment of infections produced by helicobacter pylori.
Inventor: ENRIQUE RAMON ANGELES ANGUIANO
IPC: C07C269/00
Filed: 2000-12-13
Abstract: The invention refers to a new use of carbamate by-products of formula 1 for the preparation of active medicaments against Helicobacter pylori, bacterial agent associated to the generation of gastric cancer. More specifically the invention refers to compounds behaving as antibacterial agents and in specific against the polymerization of tubulin, basic element in the constitution of Helicobacter pylori; the invention also refers to pharmaceutical compositions containing an active principle of compounds formula 1 and a pharmaceutically acceptable excipient.
Patent MX-PA01008737-A (MX)
Title: Process for the selective preparation of dib from an i-butene-containing c4 stream.
Inventor: HANS-JOACHIM KRAMER
IPC: C07C11/02
Filed: 2001-08-29
Abstract: The invention relates to a process for preparing diisobutylene (DIB) from an i-butene-containing C4 raffinate I, in which the C4 stream is passed through a first hydroisomerization reactor (A) and a fractionation column (B) and is thus largely freed of 1-butene and 2-butene. It is subsequently dimerized over an acidic catalyst installed in a reactive column (E). The feed stream to this reactive column contains not only i-butene but also butanes which make the reaction temperature in the fixed bed controllable by removal of the heat of reaction. In the fractionation column (B), a side stream can be subjected to a further hydroisomerization in a reactor (C).
Patent MX-PA01010148-A (MX)
Inventor: COCHRAN MARK D
IPC: C12N15/861
Filed: 2000-04-07
Abstract: La presente invención proporciona vectores virales;en una modalidad, la presente invención proporciona adenovirus bovino mutante y recombinante que tiene una supresión y/o inserción de ADN en la región 4 del gen temprano (E4);en otra modalidad, la presente invención proporciona un virus de adenovirus bovino 1 mutante y recombinante que tiene una supresión y/o inserción de ADN en la región 3 de gen temprano (E3);la presente invención también contempla el uso de los vectores virales para vacunación, terapia de genes u otras aplicaciones según sea adecua
Patent MX-PA01010749-A (MX)
Title: Method for treating neurodegeneration.
Inventor: EIICHI OTOMO
IPC: A61P25/00
Filed: 2001-02-23
Abstract: N (2,6 dimethylphenyl) 2 (2 oxo 1 pyrrolidinyl)acetamide is used for the preparation of medicaments, particularly of pharmaceutical compositions containing it as an active ingredient, for the treatment of neurodegeneration, in particular in post stroke human patients. The early administration of nefiracetam in said pharmaceutical compositions after a stroke allows an improvement of the Activities of Daily Living and the recovery, or at least in improvement in the recovery of, the post stroke patients.
Patent MX-PA01011410-A (MX)
Title: Cooling water recirculating process in distillation columns.
Inventor: EDITH ALEJANDRA CRUZ SUAREZ
Filed: 2001-11-09
Abstract: The present invention is designed for operating in the hydrocarbons cooling generated in the separation of an atmospheric distillation by means of water at the distillation column and comprises an arrangement so that water can re-circulate by means of a pump to the cooling external parts of the distillation column and then, returns falling in an ices bath. Likewise, water can be recycled because during the distillation process it can be stored in receptacles for its reuse and avoid the waste of it. The flow quantity will be regulated while water temperature increases and it must follow a laminar flow according to the Reynolds number for increasing or decreasing the temperature in the procedure of the present invention.